February 1, 2013Giornale italiano di cardiologia
Endocardite su protesi aortica 6 mesi dopo l’impianto transcatetere
Key result
Surgical bioprosthetic replacement successfully treats acute enterococcal endocarditis following transapical TAVI.
- n=1
Why the study?
Susceptibility to endocarditis after transcatheter aortic valve implantation (TAVI) had not yet been described.
Comparison
Surgical replacement of prosthetic valve with 23 mm Mitroflow bioprosthesis and abscess closure
Design
Case report
Follow-up
6 months
Authors
Discussion
Loading...
Member takes
Implication
May support surgical replacement for post-TAVI endocarditis in select cases; leaves open optimal management pending larger studies.
Study Design
Type
Case Report (n=1)
Structured PICO
P
Population
One 83-year-old woman who developed acute aortic prosthetic valve endocarditis 6 months after undergoing transapical TAVI.
I
Intervention
Surgical replacement of the prosthetic aortic valve with a 23 mm Mitroflow aortic bioprosthesis and closure of abscess cavity with a pericardial patch
O
Outcome
Successful treatment of acute aortic prosthetic valve endocarditis
This is the first reported case of acute aortic prosthetic valve endocarditis after transapical TAVI, demonstrating that surgical treatment can be successful.
Cite This Study
Santarpino et al. (2013) conducted a case report in Acute aortic prosthetic valve endocarditis after TAVI (n=1). Surgical replacement with a bioprosthesis and pericardial patch closure was evaluated on Successful treatment with surgery. Surgical replacement with a bioprosthesis successfully treated acute aortic prosthetic valve endocarditis caused by Enterococcus faecalis 6 months after transapical TAVI in an 83-year-old woman.